Ashby E, Janes H, Follmann D, Gilbert PB, et al. Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up. Am J Epidemiol 2026;195:168-177.
PMID: 40838594